06-Oct-2022 | Facts and Factors
According to Facts and Factors, the global Orthokeratology Lens market size was estimated to be worth roughly USD 625.83 million in 2021 and is predicted to grow to around USD 1001.66 million by 2028. The global Orthokeratology Lens market is predicted to grow at a CAGR of roughly 6.95% during the forecast period.
Ortho-K is currently used most frequently in clinical settings to flatten the cornea in order to reduce myopia. The concept of corneal replacement underlies orthokeratology (Ortho-K), a non-invasive treatment option for myopia, hyperopia, astigmatism, and presbyopia. Vision Shaping Treatment (VST) and Corneal Refractive Therapy are two Ortho-K treatments that have received FDA approval (CRT).
Browse the full “Orthokeratology Lens Market Size, Share, Growth Analysis Report By Product Type (Day-time Ortho-K Lenses, Overnight Ortho-K Lenses), By Indication (Myopia, Presbyopia, Hypermetropia, Astigmatism), By Distribution Channel (Hospitals, Optometry Clinics, Ophthalmology Clinics, Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/orthokeratology-lens-market
By helping to eliminate vision defects brought on by contact lenses, orthokeratology enables patients to lead active lives. This significant aspect is anticipated to drive the growth of the global orthokeratology market. Additionally, the worldwide orthokeratology market is anticipated to grow in the coming years due to rising online education and information about Ortho-K as well as an increase in recent orthokeratology lens success stories.
Around the world, high myopia and myopia are becoming more prevalent. High myopia is the second leading global cause of vision impairment, making it a critical public health concern. According to a National Center for Biotechnology Information (NCBI) 2016 research, myopia affects 90% of students and around 50% of the urban population in East Asia. Myopia affects the quality of life earlier than other types of blindness, such as cataracts, because it results in vision deficits early. The expense of eye diseases in the United States is over USD 139 billion, according to a 2018 study that was published in the Eye Contact Lens journal, with almost USD 16 billion going toward myopia correction alone. As a result, orthokeratology lenses and other techniques for preventing myopia and controlling its progression are highly sought after globally. Furthermore, children’s and teenagers' eyes suffer long-term harm from using cell phones, laptops, and tablets for extended periods of time. The best candidates for orthokeratology are young people whose near-sightedness is progressively getting worse. Together, all of these factors are anticipated to increase demand for Ortho-K and advance the global orthokeratology market.
No one has been treated well by COVID-19 in terms of their physical, mental, or emotional state. Seeing loved ones die as a result of the epidemic causes people to experience emotional sorrow. Work-from-home arrangements were made possible by workplace lockdowns, and people's eyesight is affected by a variety of early morning, midday, and night shifts. The quality of the medications and facilities that will support the treatment of people with vision impairments is something that government organizations are working to improve. Additionally, suppliers of orthokeratology lenses are creating and promoting solutions on a global scale in order to reach the target market and profit from the possibility of global expansion.
Additionally, the growing use of enhanced and innovative ortho k lenses is anticipated to support the expansion of the orthokeratology industry. Ortho K lenses are contact lenses that reshape the cornea and are intended to reduce or treat myopia. While the patient is sleeping, Ortho K lenses softly reposition the cornea's front surface. After the lenses are removed, the patient can go without wearing glasses during the day because their vision is clear.
The global Orthokeratology Lens market is segmented based on product type, indication, distribution channel, and region.
The global market has been further divided into daytime ortho-K-lens and nocturnal ortho-K-lens based on product kinds. In 2021, the nightly ortho-K-lenses product type category held the most market share and dominated the world. This expansion was attributable to the ortho-K-lens' rapid adoption and efficiency.
The global market is divided into myopia, presbyopia, hypermetropia, astigmatism, and others based on indications. In 2021, the myopia category was the dominant one. The market for orthokeratology lenses is anticipated to benefit from the rising prevalence of myopia during the study period. For instance, roughly 27% of the world's population, or approximately 1.9 billion people, have myopia, according to the journal Investigative Ophthalmology and Visual Science.
The market is divided into hospitals, ophthalmology clinics, optometry clinics, and others based on the distribution channels used. In 2021, the hospitals sector was the largest. The market is developing as a result of hospitals continuously increasing their investments in orthokeratology lenses as eye-related illnesses including cataracts and glaucoma are becoming more common.
In 2021, North America led the global orthokeratology lens market. Recent developments in orthokeratology lenses, the introduction of nighttime ortho-K lenses, flexibility, and choice are some of the elements anticipated to drive the regional market expansion. It is predicted that there would be significant development prospects in the U.S. due to rising orthokeratology lens usage and an increase in cases of vision impairment. Additionally, it is anticipated that the local presence of significant market participants in the U.S., including CooperVision, Johnson & Johnson Vision, and Bausch & Lomb Inc., will probably promote regional growth. The region of Europe, which had the second-highest revenue share, is anticipated to grow significantly over the course of the projected period.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 625.83 Million |
Projected Market Size in 2028 |
USD 1001.66 Million |
CAGR Growth Rate |
6.95% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Bausch & Lomb Inc., Euclid Systems Corp., CooperVision, Johnson & Johnson Vision Care Inc., Alpha Corporation (Menicon Group), Brighten Optix Co., GP Specialists, TruForm Optics Inc., Art Optical Contact Lens Inc., MiracLens L.L.C., and others. |
Key Segment |
By Product Type, Indication, Distribution Channel, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
List of prominent players in the global orthokeratology lens market
- Bausch & Lomb Inc.
- Euclid Systems Corp.
- CooperVision
- Johnson & Johnson Vision Care, Inc.
- Alpha Corporation (Menicon Group)
- Brighten Optix, Co.
- GP Specialists
- TruForm Optics, Inc.
- Art Optical Contact Lens, Inc.
- MiracLens L.L.C.
- Others
Recent Developments:
In January 2019, Contamac introduced Optimum infinite high-oxygen gas permeable contact lenses with a strong mix of processability and elastic strength.
In March 2019, Alcon, Inc. purchased PowerVision, Inc., a medical equipment development firm based in the United States. With this agreement, the company will be able to focus on developing a fluid-based corneal lens surgery. This will enhance the overall engagement of the company
The global Orthokeratology Lens market is segmented as follows:
By Product Type
- Day-time Ortho-K Lenses
- Overnight Ortho-K Lenses
By Indication
- Myopia
- Presbyopia
- Hypermetropia
- Astigmatism
By Distribution Channel
- Hospitals
- Optometry Clinics
- Ophthalmology Clinics
- Others
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com
